Sirtuins Link Inflammation and Metabolism

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Vachharajani, Vidula T ^a   Liu, Tiefu ^a,b   Wang, Xianfeng ^a   Hoth, Jason J ^a   Yoza, Barbara K ^a   McCall, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRTUIN; TOBACCO SMOKE; ADENOSINE TRIPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GLYCOLYSIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; LUNG INJURY; METABOLIC SYNDROME X; METABOLISM; NONHUMAN; OBESITY; REVIEW; SEPSIS; STRESS; ANIMAL; BIOSYNTHESIS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; ANIMALS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; NAD; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEPSIS; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84958568138     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/8167273     Document Type: Review

References (93)

1. S.-I. Imai and L. Guarente, "NAD+ and sirtuins in aging and disease, " Trends in Cell Biology, vol. 24, no. 8, pp. 464-471, 2014.
2. A. J. S. Klar, S. Fogel, and K. Macleod, "Mar1-a regulator of the HMa and HMα loci in Saccharomyces cerevisiae, " Genetics, vol. 93, no. 1, pp. 37-50, 1979.
3. J. Rine and I. Herskowitz, "Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae, " Genetics, vol. 116, no. 1, pp. 9-22, 1987.
4. S. Michan and D. Sinclair, "Sirtuins in mammals: insights into their biological function, " The Biochemical Journal, vol. 404, no. 1, pp. 1-13, 2007.
5. R. Weindruch, R. L. Walford, S. Fligiel, and D. Guthrie, "The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake, " The Journal of Nutrition, vol. 116, no. 4, pp. 641-654, 1986.
6. L. Guarente, "Sir2 links chromatin silencing, metabolism, and aging, " Genes & Development, vol. 14, no. 9, pp. 1021-1026, 2000.
7. B. Lakowski and S. Hekimi, "Determination of life-span in Caenorhabditis elegans by four clock genes, " Science, vol. 272, no. 5264, pp. 1010-1013, 1996.
8. I. Muller, M. Zimmermann, D. Becker, and M. Flomer, "Calendar life span versus budding lifespan of Saccharomyces cerevisiae, " Mechanisms of Ageing and Development, vol. 12, no. 1, pp. 47-52, 1980.
9. G. S. Roth, D. K. Ingram, and M. A. Lane, "Calorie restriction in primates: will it work and how will we know?" Journal of the American Geriatrics Society, vol. 47, no. 7, pp. 896-903, 1999.
10. L. Guarente, "Sirtuins, aging, and metabolism, " Cold Spring Harbor Symposia on Quantitative Biology, vol. 76, pp. 81-90, 2011.
11. A. Purushotham, T. T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li, "Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, " Cell Metabolism, vol. 9, no. 4, pp. 327-338, 2009.
12. M. C. Haigis, R. Mostoslavsky, K. M. Haigis et al. , "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic βcells, " Cell, vol. 126, no. 5, pp. 941-954, 2006.
13. S.-I. Imai, "The NAD world: a new systemic regulatory network for metabolism and aaging-Sirt1, systemic NAD biosynthesis, and their importance, " Cell Biochemistry and Biophysics, vol. 53, no. 2, pp. 65-74, 2009.
14. A. P. Gomes, N. L. Price, A. J. Y. Ling et al. , "Declining NAD+ induces a pseudohypoxic state disrupting nuclearmitochondrial communication during aging, " Cell, vol. 155, no. 7, pp. 1624-1638, 2013.
15. S. Kugel and R. Mostoslavsky, "Chromatin and beyond: the multitasking roles for SIRT6, " Trends in Biochemical Sciences, vol. 39, no. 2, pp. 72-81, 2014.
16. R. Mostoslavsky, K. F. Chua, D. B. Lombard et al. , "Genomic instability and aging-like phenotype in the absence of mammalian SIRT6, " Cell, vol. 124, no. 2, pp. 315-329, 2006.
17. J. Xie, X. Zhang, and L. Zhang, "Negative regulation of inflammation by SIRT1, " Pharmacological Research, vol. 67, no. 1, pp. 60-67, 2013.
18. Y. Tao, C. Huang, Y. Huang et al. , "SIRT4 suppresses inflammatory responses in human umbilical vein endothelial cells, " Cardiovascular Toxicology, vol. 15, no. 3, pp. 217-223, 2015.
19. J. Du, Y. Zhou, X. Su et al. , "Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase, " Science, vol. 334, no. 6057, pp. 806-809, 2011.
20. L. Shi and B. P. Tu, "Acetyl-CoA and the regulation of metabolism: mechanisms and consequences, " Current Opinion in Cell Biology, vol. 33, pp. 125-131, 2015.
21. T. F. Liu, C. M. Brown, M. E. Gazzar et al. , "Fueling the flame: bioenergy couples metabolism and inflammation, " Journal of Leukocyte Biology, vol. 92, no. 3, pp. 499-507, 2012.
22. A. F. McGettrick and L. A. J. ONeill, "How metabolism generates signals during innate immunity and inflammation, " The Journal of Biological Chemistry, vol. 288, no. 32, pp. 22893-22898, 2013.
23. O. Warburg, K. Gawehn, and A. W. Geissler AW, "Metabolism of leukocytes, " Zeitschrift fur Naturforschung-Teil B: Chemie, Biochemie, Biophysik, Biologie, vol. 13, no. 8, pp. 515-516, 1958.
24. A. Vazquez, J. Liu, Y. Zhou, and Z. N. Oltvai, "Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited, " BMC Systems Biology, vol. 4, article 58, 2010.
25. J.-W. Kim, I. Tchernyshyov, G. L. Semenza, and C. V. Dang, "HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, " Cell Metabolism, vol. 3, no. 3, pp. 177-185, 2006.
26. G. L. Semenza, "Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1, " The Biochemical Journal, vol. 405, no. 1, pp. 1-9, 2007.
27. G. L. Semenza, "Regulation of metabolism by hypoxiainducible factor 1, " Cold SpringHarbor Symposia onQuantitative Biology, vol. 76, pp. 347-353, 2011.
28. K. Nishi, T. Oda, S. Takabuchi et al. , "LPS induces hypoxiainducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner, " Antioxidants & Redox Signaling, vol. 10, no. 5, pp. 983-995, 2008.
29. S. R. Walmsley, C. Print, N. Farahi et al. , "Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NFkappaB activity, " Journal of ExperimentalMedicine, vol. 201, no. 1, pp. 105-115, 2005.
30. T. F. Liu, V. T. Vachharajani, B. K. Yoza, and C. E. McCall, "NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch fromglucose to fatty acid oxidation during the acute inflammatory response, "The Journal of Biological Chemistry, vol. 287, no. 31, pp. 25758-25769, 2012.
31. L. Zhong, A. DUrso, D. Toiber et al. , "The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α, " Cell, vol. 140, no. 2, pp. 280-293, 2010.
32. G. M. Tannahill, A. M. Curtis, J. Adamik et al. , "Succinate is an inflammatory signal that induces IL-1β through HIF-1α, " Nature, vol. 496, no. 7444, pp. 238-242, 2013.
33. C. M. Krawczyk, T. Holowka, J. Sun et al. , "Toll-like receptorinduced changes in glycolyticmetabolism regulate dendritic cell activation, " Blood, vol. 115, no. 23, pp. 4742-4749, 2010.
34. P. J. Fernandez-Marcos and J. Auwerx, "Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis, " The American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 884S-890S, 2011.
35. R. Nogueiras, K. M. Habegger, N. Chaudhary et al. , "Sirtuin and sirtuin 3: physiological modulators of metabolism, " Physiological Reviews, vol. 92, no. 3, pp. 1479-1514, 2012.
36. X. Li, "SIRT1 and energy metabolism, " Acta Biochimica et Biophysica Sinica, vol. 45, no. 1, pp. 51-60, 2013.
37. T. F. Liu, V. Vachharajani, P. Millet, M. S. Bharadwaj, A. J. Molina, and C. E. McCall, "Sequential actions of SIRT1-RELBSIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis, "The Journal of Biological Chemistry, vol. 290, no. 1, pp. 396-408, 2015.
38. K. A. Moynihan, A. A. Grimm, M. M. Plueger et al. , "Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice, " Cell Metabolism, vol. 2, no. 2, pp. 105-117, 2005.
39. T. T. Schug and X. Li, "Sirtuin 1 in lipidmetabolismand obesity, " Annals of Medicine, vol. 43, no. 3, pp. 198-211, 2011.
40. J. I. Odegaard, R. R. Ricardo-Gonzalez, A. Red Eagle et al. , "Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance, " Cell Metabolism, vol. 7, no. 6, pp. 496-507, 2008.
41. T. T. Schug and X. Li, "Surprising sirtuin crosstalk in the heart, " Aging, vol. 2, no. 3, pp. 129-132, 2010.
42. W. Qin, T. Yang, L. Ho et al. , "Neuronal SIRT1 activation as a novel mechanism underlying the prevention of alzheimer disease amyloid neuropathology by calorie restriction, " The Journal of Biological Chemistry, vol. 281, no. 31, pp. 21745-21754, 2006.
43. L. Serrano-Marco, M. R. Chacon, E. Maymo-Masip et al. , " TNF-αinhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes, " Biochimica et Biophysica Acta, vol. 1821, no. 9, pp. 1177-1185, 2012.
44. M. C. Haigis and D. A. Sinclair, "Mammalian sirtuins: biological insights and disease relevance, " Annual Review of Pathology: Mechanisms of Disease, vol. 5, pp. 253-295, 2010.
45. J. I. Odegaard and A. Chawla, "Mechanisms of macrophage activation in obesity-induced insulin resistance, " Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 11, pp. 619-626, 2008.
46. F. Picard, M. Kurtev, N. Chung et al. , "Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-β, " Nature, vol. 429, no. 6993, pp. 771-776, 2004.
47. S.-I. Imai and W. Kiess, "Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes, " Frontiers in Bioscience, vol. 14, no. 8, pp. 2983-2995, 2009.
48. L. Bordone, M. C. Motta, F. Picard et al. , "Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells, " PLoS Biology, vol. 4, no. 2, article e31, 2006.
49. S. Sharma, C. S. Misra, S. Arumugam et al. , "Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes, " Phytotherapy Research, vol. 25, no. 1, pp. 67-73, 2011.
50. K. P. Goh, H. Y. Lee, D. P. Lau, W. Supaat, Y. H. Chan, and A. F. Y. Koh, "Effects of resveratrol in patients with type diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure, " International Journal of Sport Nutrition and Exercise Metabolism, vol. 24, no. 1, pp. 2-13, 2014.
51. S. Stein, C. Lohmann, N. Schafer et al. , "SIRT1 decreases Lox-1-mediated foamcell formation in atherogenesis, " EuropeanHeart Journal, vol. 31, no. 18, pp. 2301-2309, 2010.
52. X. Li, S. Zhang, G. Blander, J. G. Tse, M. Krieger, and L. Guarente, "SIRT1 deacetylates and positively regulates the nuclear receptor LXR, " Molecular Cell, vol. 28, no. 1, pp. 91-106, 2007.
53. C. W. Bales and W. E. Kraus, "Caloric restriction: implications for human cardiometabolic health, " Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 33, no. 4, pp. 201-208, 2013.
54. T. Yamamoto, J. Byun, P. Zhai, Y. Ikeda, S. Oka, and J. Sadoshima, "Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion, " PLoS ONE, vol. 9, no. 6, Article ID e98972, 2014.
55. G. A. Porter, W. R. Urciuoli, P. S. Brookes, and S. M. Nadtochiy, "SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts, " American Journal of Physiology- Heart and Circulatory Physiology, vol. 306, no. 12, pp. H1602-H1609, 2014.
56. M. Shalwala, S.-G. Zhu, A. Das, F. N. Salloum, L. Xi, and R. C. Kukreja, "Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice, " PLoS ONE, vol. 9, no. 1, Article ID e86977, 2014.
57. C. Tong, A. Morrison, S. Mattison et al. , "Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress, " The FASEB Journal, vol. 27, no. 11, pp. 4332-4342, 2013.
58. H.-T. Zeng, Y.-C. Fu, W. Yu et al. , "SIRT1 prevents atherosclerosis via liver-X-receptor and NF-κB signaling in a U937 cell model, " Molecular Medicine Reports, vol. 8, no. 1, pp. 23-28, 2013.
59. B. Bai, P. M. Vanhoutte, and Y. Wang, "Loss-of-SIRT1 function during vascular ageing: hyperphosphorylation mediated by cyclin-dependent kinase 5, " Trends in Cardiovascular Medicine, vol. 24, no. 2, pp. 81-84, 2014.
60. A. Toniolo, E. A. Warden, A. Nassi, A. Cignarella, and C. Bolego, "Regulation of SIRT1 in vascular smooth muscle cells from streptozotocin-diabetic rats, " PLoS ONE, vol. 8, no. 5, Article ID e65666, 2013.
61. D. Kim, M. D. Nguyen, M. M. Dobbin et al. , "SIRT1 deacetylase protects against neurodegeneration in models for Alzheimers disease and amyotrophic lateral sclerosis, " The EMBO Journal, vol. 26, no. 13, pp. 3169-3179, 2007.
62. S. S. Karuppagounder, J. T. Pinto, H. Xu, H.-L. Chen, M. F. Beal, and G. E. Gibson, "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimers disease, " Neurochemistry International, vol. 54, no. 2, pp. 111-118, 2009.
63. G. Donmez, D. Wang, D. E. Cohen, and L. Guarente, "SIRT1 suppresses β-amyloid production by activating the α-secretase gene ADAM10, " Cell, vol. 142, no. 2, pp. 320-332, 2010.
64. Y. J. Jung, J. E. Lee, A. S. Lee et al. , "SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells, " Biochemical and Biophysical Research Communications, vol. 419, no. 2, pp. 206-210, 2012.
65. D. H. Kim, Y. J. Jung, J. E. Lee et al. , "Sirt1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53, " American Journal of Physiology-Renal Physiology, vol. 301, no. 2, pp. F427-F435, 2011.
66. H. Fan, H.-C. Yang, L. You, Y.-Y. Wang, W.-J. He, and C.-M. Hao, "The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury, " Kidney International, vol. 83, no. 3, pp. 404-413, 2013.
67. M. Morigi, L. Perico, C. Rota et al. , "Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury, "The Journal of Clinical Investigation, vol. 125, no. 2, pp. 715-726, 2015.
68. H. Yao, I. K. Sundar, T. Ahmad et al. , "SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism, " The American Journal of Physiology- Lung Cellular and Molecular Physiology, vol. 306, no. 9, pp. L816-L828, 2014.
69. J.-W. Hwang, H. Yao, S. Caito, I. K. Sundar, and I. Rahman, "Redox regulation of SIRT1 in inflammation and cellular senescence, " Free Radical Biology&Medicine, vol. 61, pp. 95-110, 2013.
70. C. Canto and J. Auwerx, "PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure, " Current Opinion in Lipidology, vol. 20, no. 2, pp. 98-105, 2009.
71. R. Medzhitov, "Inflammation 2010: new Adventures of an Old Flame, " Cell, vol. 140, no. 6, pp. 771-776, 2010.
72. J. Chang, S. L. Kunkel, and C.-H. Chang, "Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 43, pp. 18327-18332, 2009.
73. L. Li, S. Cousart, J. Hu, and C. E. McCall, "Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells, " The Journal of Biological Chemistry, vol. 275, no. 30, pp. 23340-23345, 2000.
74. P. B. Beeson, "Tolerance to bacterial pyrogens, " The Journal of Experimental Medicine, vol. 86, pp. 29-41, 1947.
75. J. A. Cook, "Molecular basis of endotoxin tolerance, " Annals of the New York Academy of Sciences, vol. 851, pp. 426-428, 1998.
76. C. E. McCall, B. Yoza, T. Liu, and M. El Gazzar, "Genespecific epigenetic regulation in serious infectionswith systemic inflammation, " Journal of Innate Immunity, vol. 2, no. 5, pp. 395-405, 2010.
77. R. Medzhitov, "Origin and physiological roles of inflammation, " Nature, vol. 454, no. 7203, pp. 428-435, 2008.
78. C. Chan, L. Li, C. E. McCall, and B. K. Yoza, "Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter, " Journal of Immunology, vol. 175, no. 1, pp. 461-468, 2005.
79. V. T. Vachharajani, T. Liu, C. M. Brown et al. , "SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome, " Journal of Leukocyte Biology, vol. 96, no. 5, pp. 785-796, 2014.
80. W. Xiao, M. N. Mindrinos, J. Seok et al. , "A genomic storm in critically injured humans, " Journal of Experimental Medicine, vol. 208, no. 13, pp. 2581-2590, 2011.
81. R. S. Hotchkiss, C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson, "The sepsis seesaw: tilting toward immunosuppression, " Nature Medicine, vol. 15, no. 5, pp. 496-497, 2009.
82. J. S. Boomer, K. To, K. C. Chang et al. , "Immunosuppression in patients who die of sepsis and multiple organ failure, " The Journal of the American Medical Association, vol. 306, no. 23, pp. 2594-2605, 2011.
83. Z. Zhang, S. F. Lowry, L. Guarente, and B. Haimovich, "Roles of SIRT1 in the acute and restorative phases following induction of inflammation, "The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41391-41401, 2010.
84. T. F. Liu, B. K. Yoza, M. El Gazzar, V. T. Vachharajani, and C. E. McCall, "NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance, " The Journal of Biological Chemistry, vol. 286, no. 11, pp. 9856-9864, 2011.
85. M. Lei, J.-G. Wang, D.-M. Xiao et al. , "Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity, " European Journal of Pharmacology, vol. 674, no. 2-3, pp. 73-79, 2012.
86. M. El Gazzar, B. K. Yoza, X. Chen, J. Hu, G. A. Hawkins, and C. E. McCall, "G9a and HP1 couple histone and DNA methylation to TNFα transcription silencing during endotoxin tolerance, " The Journal of Biological Chemistry, vol. 283, no. 47, pp. 32198-32208, 2008.
87. V. Vachharajani, T. Liu, and C. E. McCall, "Epigenetic coordination of acute systemic inflammation: potential therapeutic targets, " Expert Review of Clinical Immunology, vol. 10, no. 9, pp. 1141-1150, 2014.
88. J. C. Newman, W. He, and E. Verdin, "Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease, "TheJournal of Biological Chemistry, vol. 287, no. 51, pp. 42436-42443, 2012.
89. A. Hasegawa, H. Iwasaka, S. Hagiwara, N. Asai, T. Nishida, and T. Noguchi, "Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture, "The Journal of Surgical Research, vol. 174, no. 1, pp. 136-141, 2012.
90. M. M. Poulsen, J. O. L. Jorgensen, N. Jessen, B. Richelsen, and S. B. Pedersen, "Resveratrol in metabolic health: an overview of the current evidence and perspectives, " Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 74-82, 2013.
91. V. Vachharajani, J. M. Russell, K. L. Scott et al. , "Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction inmouse brain, "Microcirculation, vol. 12, no. 2, pp. 183-194, 2005.
92. X. Wang, N. L. Buechler, B. K. Yoza, C. E. McCall, and V. T. Vachharajani, "Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice, " Obesity, vol. 23, no. 6, pp. 1209-1217, 2015.
93. L. M. Smith, J. D. Wells, V. T. Vachharajani, B. K. Yoza, C. E. McCall, and J. J. Hoth, "SIRT1 mediates a primed response to immune challenge after traumatic lung injury, " The Journal of Trauma and Acute Care Surgery, vol. 78, no. 5, pp. 1034-1038, 2015.